Cargando…
Comparative proteome analysis of Tumor necrosis factor α-stimulated human Vascular Smooth Muscle Cells in response to melittin
BACKGROUND: Bee venom has been used to relieve pain and to treat inflammatory diseases, including rheumatoid arthritis, in humans. To better understand the mechanisms of the anti-inflammatory and anti-atherosclerosis effect of bee venom, gel electrophoresis and mass spectrometry were used to identif...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655938/ https://www.ncbi.nlm.nih.gov/pubmed/23651618 http://dx.doi.org/10.1186/1477-5956-11-20 |
_version_ | 1782269952382730240 |
---|---|
author | Cho, Hyun-Ji Kang, Jeong-Han Park, Kwan-Kyu Choe, Jung-Yoon Park, Yoon-Yub Moon, Yong-Suk Chung, Il-Kyung Chang, Hyeun-Wook Kim, Cheorl-Ho Choi, Yung Hyun Kim, Wun-Jae Moon, Sung-Kwon Chang, Young-Chae |
author_facet | Cho, Hyun-Ji Kang, Jeong-Han Park, Kwan-Kyu Choe, Jung-Yoon Park, Yoon-Yub Moon, Yong-Suk Chung, Il-Kyung Chang, Hyeun-Wook Kim, Cheorl-Ho Choi, Yung Hyun Kim, Wun-Jae Moon, Sung-Kwon Chang, Young-Chae |
author_sort | Cho, Hyun-Ji |
collection | PubMed |
description | BACKGROUND: Bee venom has been used to relieve pain and to treat inflammatory diseases, including rheumatoid arthritis, in humans. To better understand the mechanisms of the anti-inflammatory and anti-atherosclerosis effect of bee venom, gel electrophoresis and mass spectrometry were used to identify proteins whose expression was altered in human Vascular Smooth Muscle Cells (hVSMCs) stimulated by tumor necrosis factor alpha after 12 h in the presence of melittin. RESULTS: To obtain valuable insights into the anti-inflammatory and anti-atherosclerosis mechanisms of melittin, two-dimensional (2-D) gel electrophoresis and MALDI-TOF/TOF were used. The proteome study, we showed 33 significant proteins that were differentially expressed in the cells treated with tumor necrosis factor alpha and melittin. Thirteen proteins were significantly increased in the cells treated with tumor necrosis factor alpha, and those proteins were reduced in the cells treated with melittin. Five of the proteins that showed increased expression in the cells treated with tumor necrosis factor alpha are involved in cell migration, including calreticulin, an essential factor of development that plays a role in transcription regulation. The proteins involved in cell migration were reduced in the melittin treated cells. The observed changes in the expression of GRP75, prohibitin, and a select group of other proteins were validated with reverse transcribed-PCR. It was confirmed that the observed change in the protein levels reflected a change in the genes level. In addition, the phosphorylation of EGFR and ERK was validated by analyzing the protein pathway. CONCLUSION: Taken together, these data established that the expression of some proteins was significantly changed by melittin treatment in tumor necrosis factor alpha stimulated the cells and provided insights into the mechanism of the melittin function for its potential use as an anti-inflammatory agent. |
format | Online Article Text |
id | pubmed-3655938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36559382013-05-17 Comparative proteome analysis of Tumor necrosis factor α-stimulated human Vascular Smooth Muscle Cells in response to melittin Cho, Hyun-Ji Kang, Jeong-Han Park, Kwan-Kyu Choe, Jung-Yoon Park, Yoon-Yub Moon, Yong-Suk Chung, Il-Kyung Chang, Hyeun-Wook Kim, Cheorl-Ho Choi, Yung Hyun Kim, Wun-Jae Moon, Sung-Kwon Chang, Young-Chae Proteome Sci Research BACKGROUND: Bee venom has been used to relieve pain and to treat inflammatory diseases, including rheumatoid arthritis, in humans. To better understand the mechanisms of the anti-inflammatory and anti-atherosclerosis effect of bee venom, gel electrophoresis and mass spectrometry were used to identify proteins whose expression was altered in human Vascular Smooth Muscle Cells (hVSMCs) stimulated by tumor necrosis factor alpha after 12 h in the presence of melittin. RESULTS: To obtain valuable insights into the anti-inflammatory and anti-atherosclerosis mechanisms of melittin, two-dimensional (2-D) gel electrophoresis and MALDI-TOF/TOF were used. The proteome study, we showed 33 significant proteins that were differentially expressed in the cells treated with tumor necrosis factor alpha and melittin. Thirteen proteins were significantly increased in the cells treated with tumor necrosis factor alpha, and those proteins were reduced in the cells treated with melittin. Five of the proteins that showed increased expression in the cells treated with tumor necrosis factor alpha are involved in cell migration, including calreticulin, an essential factor of development that plays a role in transcription regulation. The proteins involved in cell migration were reduced in the melittin treated cells. The observed changes in the expression of GRP75, prohibitin, and a select group of other proteins were validated with reverse transcribed-PCR. It was confirmed that the observed change in the protein levels reflected a change in the genes level. In addition, the phosphorylation of EGFR and ERK was validated by analyzing the protein pathway. CONCLUSION: Taken together, these data established that the expression of some proteins was significantly changed by melittin treatment in tumor necrosis factor alpha stimulated the cells and provided insights into the mechanism of the melittin function for its potential use as an anti-inflammatory agent. BioMed Central 2013-05-07 /pmc/articles/PMC3655938/ /pubmed/23651618 http://dx.doi.org/10.1186/1477-5956-11-20 Text en Copyright © 2013 Cho et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Cho, Hyun-Ji Kang, Jeong-Han Park, Kwan-Kyu Choe, Jung-Yoon Park, Yoon-Yub Moon, Yong-Suk Chung, Il-Kyung Chang, Hyeun-Wook Kim, Cheorl-Ho Choi, Yung Hyun Kim, Wun-Jae Moon, Sung-Kwon Chang, Young-Chae Comparative proteome analysis of Tumor necrosis factor α-stimulated human Vascular Smooth Muscle Cells in response to melittin |
title | Comparative proteome analysis of Tumor necrosis factor α-stimulated human Vascular Smooth Muscle Cells in response to melittin |
title_full | Comparative proteome analysis of Tumor necrosis factor α-stimulated human Vascular Smooth Muscle Cells in response to melittin |
title_fullStr | Comparative proteome analysis of Tumor necrosis factor α-stimulated human Vascular Smooth Muscle Cells in response to melittin |
title_full_unstemmed | Comparative proteome analysis of Tumor necrosis factor α-stimulated human Vascular Smooth Muscle Cells in response to melittin |
title_short | Comparative proteome analysis of Tumor necrosis factor α-stimulated human Vascular Smooth Muscle Cells in response to melittin |
title_sort | comparative proteome analysis of tumor necrosis factor α-stimulated human vascular smooth muscle cells in response to melittin |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655938/ https://www.ncbi.nlm.nih.gov/pubmed/23651618 http://dx.doi.org/10.1186/1477-5956-11-20 |
work_keys_str_mv | AT chohyunji comparativeproteomeanalysisoftumornecrosisfactorastimulatedhumanvascularsmoothmusclecellsinresponsetomelittin AT kangjeonghan comparativeproteomeanalysisoftumornecrosisfactorastimulatedhumanvascularsmoothmusclecellsinresponsetomelittin AT parkkwankyu comparativeproteomeanalysisoftumornecrosisfactorastimulatedhumanvascularsmoothmusclecellsinresponsetomelittin AT choejungyoon comparativeproteomeanalysisoftumornecrosisfactorastimulatedhumanvascularsmoothmusclecellsinresponsetomelittin AT parkyoonyub comparativeproteomeanalysisoftumornecrosisfactorastimulatedhumanvascularsmoothmusclecellsinresponsetomelittin AT moonyongsuk comparativeproteomeanalysisoftumornecrosisfactorastimulatedhumanvascularsmoothmusclecellsinresponsetomelittin AT chungilkyung comparativeproteomeanalysisoftumornecrosisfactorastimulatedhumanvascularsmoothmusclecellsinresponsetomelittin AT changhyeunwook comparativeproteomeanalysisoftumornecrosisfactorastimulatedhumanvascularsmoothmusclecellsinresponsetomelittin AT kimcheorlho comparativeproteomeanalysisoftumornecrosisfactorastimulatedhumanvascularsmoothmusclecellsinresponsetomelittin AT choiyunghyun comparativeproteomeanalysisoftumornecrosisfactorastimulatedhumanvascularsmoothmusclecellsinresponsetomelittin AT kimwunjae comparativeproteomeanalysisoftumornecrosisfactorastimulatedhumanvascularsmoothmusclecellsinresponsetomelittin AT moonsungkwon comparativeproteomeanalysisoftumornecrosisfactorastimulatedhumanvascularsmoothmusclecellsinresponsetomelittin AT changyoungchae comparativeproteomeanalysisoftumornecrosisfactorastimulatedhumanvascularsmoothmusclecellsinresponsetomelittin |